AGP Picks
View all

Your daily news update on Asia and the Pacific

Provided by AGP

The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on April 2, 2026

REVEALED: How much parents will pay to educate their child in Singapore
SPARC AI Releases Latest Investor Presentation
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Refined Energy Completes Maiden Drill Program at Dufferin West, Intersects Unconformity
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cheer Holding Announces Share Consolidation of Class A Ordinary Shares
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer 
Tokyo Lifestyle Secures US$2.56 Million Investment from Private Strategic Investor to Strengthen Operations and Expansion in Hong Kong
Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy
Pony AI Inc. Announces Results of Extraordinary General Meeting, Class A Meeting, and Class B Meeting
NevGold Announces Up to 99% Gold Recovery From Phase II Metallurgical Testwork on Oxide Antimony-Gold; Identifies More Antimony Mineralization At Surface In Historical Gold Waste Dump
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
Multiple Large Chargeability Features Support Porphyry/CRD Targets at Smart Creek Project, Montana
NIOB Launches Diamond Drill Program at Seigneurie
Namib Minerals Provides Business Update and Reports Full Year 2025 Results
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response
Neutrolis Announces Positive First-in-Human Phase 1a Results from LIBERATE-I Trial of NTR-1011, a First-in-Class DNASE1L3 Fusion Protein
Hudbay Announces Repayment of 2026 Senior Unsecured Notes

Share us

on your social networks:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.